Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy☆

[1]  S. Kochhar,et al.  Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data☆ , 2016, Vaccine.

[2]  S. Omer,et al.  A systematic review of adverse events following immunization during pregnancy and the newborn period , 2015, Vaccine.

[3]  F. Muñoz.  Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy? , 2015, Current opinion in infectious diseases.

[4]  N. Andrews,et al.  A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  N. Andrews,et al.  Effectiveness of maternal pertussis vaccination in England: an observational study , 2014, The Lancet.

[6]  Stephanie A. Jones,et al.  Influenza vaccination of pregnant women and protection of their infants. , 2014, The New England journal of medicine.

[7]  Robert T. Chen,et al.  Template protocol for clinical trials investigating vaccines--focus on safety elements. , 2013, Vaccine.

[8]  P. Heath.  An update on vaccination against group B streptococcus , 2011, Expert review of vaccines.

[9]  S. Cousens,et al.  Tetanus toxoid immunization to reduce mortality from neonatal tetanus , 2010, International journal of epidemiology.

[10]  A. Shane.  Effectiveness of Maternal Influenza Immunization in Mothers and Infants , 2009 .